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Abstract
Background: Depression is common among women during perinatal period and is associated with long-term adverse
consequences for the mother and infant. In Nigeria, as in many other low- and-middle-income countries (LMIC),
perinatal depression usually goes unrecognized and untreated. The aim of EXPONATE is to test the effectiveness and
cost-effectiveness of an intervention package for perinatal depression delivered by community midwives in primary
maternal care in which physician support and enhanced patient compliance are implemented using mobile phones.
Methods/Study design: A pragmatic two-arm parallel cluster randomized controlled trial was designed. The units of
allocation are the primary maternal care clinics. Thirty eligible and consenting clinics were randomized but, due to
problems with logistics, 29 eventually participated. Consenting pregnant women with a gestational age between 16
and 28 weeks who screened positive on the Edinburgh Postnatal Depression Scale (EPDS score ≥12), absent psychosis
or bipolar disorder, and not actively suicidal were recruited into the trial (N = 686). Midwives in the intervention arm
were trained to deliver psychoeducation, problem solving treatment, and parenting skills. Eight weekly sessions were
delivered following entry into the study. Further sessions during pregnancy and 6 weeks following childbirth were
determined by level of depressive symptoms. Clinical support and supervision, delivered mainly by mobile phone, were
provided by general physicians and psychiatrists. Automated text and voice messages, also delivered by mobile phones,
were used to facilitate patient compliance with clinic appointments and ‘homework’ tasks. Patients in the control arm
received care as usual enhanced by further training of the providers in that arm in the recognition and standard
treatment of depression. Assessments are undertaken at baseline, 2 months following recruitment into the study and
3, 6, 9 and 12 months after childbirth. The primary outcome is recovery from depression (EPDS < 6) at 6 months.
Secondary outcomes include measures of disability, parenting skills, maternal attitudes, health care utilization as well as
infant physical and cognitive development comprehensively assessed using the Bayley’s Scales.
Discussion: To the best of our knowledge, this is the largest randomized controlled trial of an intervention package
delivered by community midwives in sub-Saharan Africa.
Trial registration: Trial is registered with the ISRTCN registry at isrtcn.com; Trial number ISRCTN60041127. Date of
registration is 15/05/2013.
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Background
Depression is one of the most common disorders in adult
life with adverse consequences for health and social well-
being [1]. More than 13 % of the global burden of disease
is due to neuropsychiatric disorders, with depression being
the leading cause of the burden [2, 3]. Epidemiological
studies conducted in Nigeria find 10–20 % of consecutive
attendees in primary care have depression [4, 5]. Depres-
sion is particularly common amongst women of child
bearing age. One systematic review estimated the point
prevalence of major and minor depression to be between
8.5 and 11 % during pregnancy and between 9.7 and
12.9 % postnatally [6]. In Nigeria, rates of up to 10–30 %
have been reported amongst perinatal women [7–11].
Perinatal depression, defined as non-psychotic depres-
sive episode often beginning during pregnancy or the post-
natal period, is a substantial public health problem, not
only because it is common but also because it is associated
with long term adverse consequences on infant develop-
ment and mother-child interactions [12]. Maternal depres-
sion is a risk factor for pre-term birth and low birth
weight, infant under-nutrition and stunting as well as
higher rates of diarrhoeal diseases [13–17]. Infants of de-
pressed mothers also show poorer infant development as
assessed using standardized measures, poorer interper-
sonal functioning, insecure attachment and elevated rates
of emotional and behavioural problems [16, 18–20].
Worldwide, only a minority of depressed persons get
the care they need [21]. Depressed women, especially
those in the perinatal period, are particularly less likely
to have their mental health needs met. It has been esti-
mated that less than 50 % of cases of postnatal depres-
sion are detected by primary health care professionals in
routine clinical practice [22]. This estimate was made for
settings with much better resourced health care systems
than are found in low and middle income countries
(LMIC). It is very likely that a much smaller proportion
of cases are identified and treated in Nigeria and other
LMIC. Hence there is a huge level of unmet need for
service in LMIC. For example, a previous study in
Nigeria found that about four out of five persons with
severe mental disorders, particularly depression, had re-
ceived no treatment in the previous year and that,
among those who did, only about 10 % had received
what could be described as minimally adequate treat-
ment [21]. The extent of the treatment gaps in LMIC re-
flects the extreme paucity of resources, both human and
material. In sub-Saharan Africa, there is less than one
psychiatrist to one million population and the few avail-
able specialists are based in urban areas [23]. Less than
2 % of the national budget goes to health and, within
this, mental health service is hardly featured [23]. In ad-
dressing these gaps, it is now commonly agreed that the
most effective way to bring health care to more people
in need is through the integration of mental health services
into routine primary care and maternal care so that non-
physician health care providers at primary health clinics or
dispensary level deliver the bulk of essential mental health
service under the supervision and support of physicians or
psychiatric nurses at district/local government level, who
are themselves supported by more highly trained mental
health specialists at regional/state levels [24].
Evidence from systematic reviews shows that perinatal
depression can, in most instances, be effectively man-
aged with psychological treatments [25, 26]. Even though
much of this evidence has come from studies in high-
income countries, previous studies in some LMIC have
also shown that psychological interventions can be deliv-
ered by non-specialist health workers, such as commu-
nity health workers (CHWs), including community
midwives (CMWs) [27–29]. The results of these studies
suggest that there is a need for training of the CMWs to
deliver the intervention in a way that is sustainable
within their day-to-day practice and that close supervi-
sion and support are available to these providers.
There is now considerable evidence in support of
stepped care approaches to expanding mental health ser-
vices [30]. In this model, non-physician primary care pro-
viders deliver the bulk of essential mental health service
under the supervision and support of physicians and of
more highly trained mental health specialists, if these are
available. The essential ingredients to scale up mental
health services to perinatal women are therefore generally
agreed upon. However, considerable challenges remain to
translate this knowledge into practice in diverse settings.
This is especially so in regard to building an integrated
treatment system out of the available resources in LMIC.
Methods/Design
Aim of the study
The primary aim of this study is to test the effectiveness and
cost-effectiveness of a stepped care intervention package for
perinatal depression delivered by community midwives in
primary maternal care, supported by physicians and mental
health specialists through the use of mobile phones, com-
pared to usual care in a randomized controlled trial.
The primary hypothesis is that the intervention package
will be more effective at alleviating depression at 6 months
after childbirth compared to care as usual. The secondary
hypotheses are that: 1) the intervention package will be
more cost-effective; 2) will lead to better infant outcomes
(in regard to cognition and growth) at 12 months; 3) will
be associated with better parental skills of mothers; and 4)
will lead to less experience of perceived stigma.
Design
This study was a two-arm parallel cluster randomized
controlled trial comparing an intervention package for
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maternal depression consisting mainly of psychological
interventions (psychoeducation, problem solving treat-
ment and parenting skills) with care as usual. The unit
of randomization was the primary maternal care clinic;
interventions and outcome measures were however ad-
ministered on individual participants. As the interven-
tion was designed to be delivered by clinic staff, the
cluster randomized design was chosen in order to re-
duce the potential risk of contamination within clinics.
Setting
The study was conducted in Oyo State, Nigeria. The
state has 33 local government areas (LGA). All 137 ma-
ternal and child care clinics (MCCs) in nine LGAs se-
lected for the study (five rural and four urban) were
assessed for eligibility to participate. MCCs are the main
source of care for most low-income perinatal women
and are therefore the appropriate place to test an inter-
vention package that is designed to make a major impact
on the delivery of care to this population. Maternal and
child health services in these clinics are largely delivered
by non-physician primary care providers and midwives,
who have been trained as nurses, community health offi-
cers and community health extension workers. Each of
these categories of providers has a minimum of 2–3 years
post-secondary education and are certified by their re-
spective boards. Supervision for all the clinics in each
LGA is provided by one general practitioner employed
by the government and designated as the Primary Health
Care Coordinator for the Local Government.
We used both urban and rural areas in order to cap-
ture the diversity of socioeconomic profile of the coun-
try and because access to medical treatment differs
substantially between these two types of setting, thus
making the demonstration of the utility of our program
potentially more generalizable.
Eligible clinics were those that offer full maternal and
child health services (n = 49). The study procedures were
described to the supervising physicians in each of the
LGAs and to the facility managers in each of the eligible
clinics. Only clinics providing explicit consent to partici-
pate were randomized into the trial. Of the 30 that did
so, one was excluded because the staffing profile was too
thin to permit for effective participation, thus leaving 29
included in the trial.
Randomization
Eligible and consenting maternal care clinics were strati-
fied by local government area and allocated to interven-
tion or control arm using a computer-generated random
number sequence. Allocation was conducted by one of
the authors (AAM) using anonymous codes for clinics
and LGAs provided by other members of the research
team, in order to avoid any risk of selection bias.
Ethics and research governance
The study was approved by the University of Ibadan/
University College Hospital Ibadan Ethical Review Com-
mittee and was conducted in strict compliance with the
guidelines specified by the Committee. The conduct and
progress of the study were monitored by three commit-
tees: 1) Trial Management Group: This was responsible
for providing study oversight including giving oper-
ational direction to the study and monitoring progress.
This Group, which had monthly teleconference and an-
nual face-to-face meetings, included the investigators
and senior researchers; 2) Trial Steering Committee: Its
role was to monitor and supervise the implementation
of the trial, ensure that there were no major deviations
from protocol specifications, and offer advice to the in-
vestigators on the scientific conduct of the trial. The
Committee was made up of three independent members
and scheduled two annual meetings, one face-to-face
and the other by teleconference. Additional teleconfer-
ence meetings were called when information from the
Principal Investigator required immediate advice; and 3)
An independent Data Monitoring and Ethics Committee
whose responsibility was to advise the TSC on ethical
and safety issues, including whether such issues could
affect the continuation of the study.
Recruitment of participants and eligibility
Considering that allocation concealment and selection
bias could be a problem in cluster randomized trials
where all participants are not consented and recruited
prior to allocation of clusters, consecutive attendees at
the selected MCCs were invited to participate by trained
research staff while waiting to see the midwife. They
were briefly educated about perinatal depression and in-
vited to take the screening interview. Those who agreed
were screened with the Edinburgh Postnatal Depression
Scale (EPDS).
Women who screened positive (EPDS score of 12 or
greater) and were eligible for the study (see eligibility
criteria below) were invited to participate in the study.
Those who provided signed consent following a full de-
scription of the study were entered into the trial. Con-
senting patients were handed their EPDS score and told
to see one of the trained CMWs in the clinic.
Women most commonly present for the first time for
antenatal care early in the second trimester in these
clinics. We aim for the findings of our study to be as
widely generalizable as possible. We therefore have very
limited exclusion criteria.
Inclusion Criteria (patients must satisfy all of the fol-
lowing to be considered for study entry)
 Women aged between 16 and 45 years.
 Gestational age of between 16 and 28 weeks.
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 Must score 12 or more on the Edinburgh Postnatal
Depression Scale, a validated cut-off score indicating
depression of at least moderate intensity. This cut-
off is supported by previous validation studies in
Nigeria [8, 31].
 Confirmed DSM-IV diagnosis of depression using
relevant questions from the Composite International
Diagnostic Interview (CIDI) [32].
 Provide informed consent.
Exclusion Criteria (patients were excluded from study
entry if any of the following was met)
 Immediate need for medical attention
 Actively suicidal
 Presence of bipolar or psychotic disorder
 Unlikely to be in the neighbourhood in the following
12 months
Interventions
The intervention package for EXPONATE was an adap-
tation of an intervention for adults with depression
which we had developed and piloted in our earlier study
of a stepped care intervention for depression in primary
care [33]. The intervention was pragmatic, fully manua-
lised, and took account of specific issues relating to
pregnancy, childbirth, marital relationships and parental
roles. It incorporated the treatment specifications of the
WHO Mental Health Gap Action Programme Interven-
tion Guide (mhGAP-IG) as adapted for the health system
of Nigeria [34]. The manual consists of a step-by-step de-
scription of psychoeducation, problem solving treatment,
social network activation and parenting skills. The inter-
vention was developed following formative research asses-
sing help seeking and experience of care for perinatal
depression and contextualization workshops with care
providers. These activities enabled us to incorporate cul-
turally relevant experiences, norms, and contexts into the
psychological component of the intervention.
The intervention package is designed to be delivered in
three steps determined by the patient’s score on the EPDS,
time since enrollment and gestational status. (See Fig. 1).
All consenting and eligible participants with a score of 12
or greater on the EPDS in the intervention arm of the trial
GA 16-28 weeks, EPDS 12 or 
more enroll into the study 
Doctor’s advice + Weekly talk 
therapy sessions for 8 weeks 
Call Doctor
EPDS 18 or more/suicidal 
6-8 additional talk therapy 
sessions over 8 weeks 
EPDS 12 - 17
2 additional talk 
therapy sessions 
EPDS less than 12 
6 weeks after delivery 
screen with EPDS 
Delivery 
2 additional talk 
therapy sessions
Fortnightly talk 
therapy sessions till 
Doctor’s advice + weekly talk 
therapy sessions till 38 weeks 
Call Doctor
EPDS 18 or 
more/suicidal
EPDS 12-17 GA 
less than 36 weeks 
EPDS less than 12 + 
GA less than 36 
Re-assess with 
EPDS 
Doctor’s advice + weekly talk 
therapy sessions for 8 weeks
Call Doctor
EPDS 18 or more/suicidal 
Commence weekly talk 
therapy sessions for 8 weeks 
EPDS 12-17 
Fig. 1 Treatment flow chart
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were enrolled into Step 1. Step 1 comprised 8 sessions of
psychological interventions delivered weekly in the ante-
natal period. At the end of these first 8 sessions, patients
whose gestational age was less than 36 weeks and who still
had depression (indicated by an EPDS score of 12 or
greater) continued with fortnightly psychological interven-
tion sessions. Step 2 commenced 6 weeks after delivery
during the mother’s routine first post-natal clinic visit. Pa-
tients were assessed by the CMW using the EPDS. Pa-
tients who scored below 12 received 4 fortnightly top-up
sessions of the problem solving treatment. Those whose
EPDS score was 12 and above received 8 weekly interven-
tion sessions. At the completion of step 2, patients who
still had EPDS scores of 12 or more proceeded to step 3.
In step 3, patients had to be reviewed by the community
physician with a view to initiating pharmacotherapy in
addition to continuing with the psychological intervention
or referral to specialist service.
Any patient in the intervention arm with a score of 18
or more or who had suicidal ideation at any time after
entry into the trial was reviewed by the community
physician who took a decision about the need for a psy-
chiatric review/referral or prescription of medication in
addition to the psychological intervention being deliv-
ered by the CMW. For patients who required medica-
tion, as assessed by the primary care physician, the first
line was amitriptyline, which non-physician primary care
providers in Nigeria are authorized to prescribe.
Each session of the psychological intervention lasted
approximately 30–45 min. The CMWs were encouraged
to schedule sessions outside of busy clinic hours and at
times that were agreeable to both the patient and the
CMW. This ensured that sessions could be conducted in
strict privacy and with less likelihood of intrusion. The
first session was dedicated mostly to familiarizing pa-
tients with the health care provider, and providing psy-
choeducation. In psychoeducation, the nature of the
patients’ illness and the modality of treatment were ex-
plained in simple language using local expressions while
avoiding the labeling of ‘mental illness/disorder’. Pa-
tients were encouraged to ask questions and were free to
express their feelings. In addition, patients were provided
with information booklets written in Yoruba and sup-
ported with pictorial representations of depression and the
intervention modalities provided in the program. Psychoe-
ducation was continued at each subsequent session.
Parenting skills and activity scheduling (behavioral ac-
tivation) were introduced from the second session. In ac-
tivity scheduling, patients worked with the CMW to
schedule activities that were important or pleasurable to
them. Patients were assisted to make a list of pleasurable
activities and household chores that they had stopped
doing on account of their depression; the CMW then
worked with the patient to select at least one to be
carried out over the next week. These activities were
noted in the patients’ record book kept in the clinic as
well as patients take-home card with ‘home work’ tasks.
‘Home work’ tasks from the preceding session were
reviewed at the beginning of the next session. The par-
enting skills component was used to emphasize routine
information provided to antenatal women (such as im-
portance of routine antenatal visits, adequate nutrition
and rest, preparation for delivery and signs that could
indicate an emergency) as well as educate the woman on
newborn care, infant nutrition and responsive parenting.
Problem solving treatment (PST) was introduced at
the third session. We delivered a local adaptation of
Problem Solving Treatment for Primary Care (PST-PC),
which had earlier been used by us in studies in primary
care. PST is an effective seven-step common sense talk
therapy that aims at helping patients resolve trouble-
some problems that contribute to causing or prolonging
the depressive episode [35, 36]. It involves working with
the patient to identify and explore the problems that
they are currently faced with and aiding the patient to
develop and implement practicable solutions. The CMW
always reviewed with patients their attempts at problem
solving at the beginning of each session, praising their
efforts and relating improvement in depression symp-
toms to their improved ability to deal with problems.
In the seventh session, using a problem solving ap-
proach, the CMW helped the patient to explore their so-
cial network with a view to selecting the most appropriate
person to provide support for the patient in terms of car-
ing for the new born, older children and household chores
following delivery. Part of the patient’s take-home tasks
for this session included contacting this caregiver. The last
antenatal session was used to review the patients’ progress,
emphasize on parenting skills learnt and encourage the
patient to continue using the problem solving skills ac-
quired in the course of the treatment sessions on their
own. Psychological sessions conducted postnatally pro-
vided opportunities to revisit the issues discussed in the
prenatal sessions, especially in light of arrival of the new
baby, explore further the issues of social (and marital) sup-
port, and parenting skills.
Control arm
Subjects who were recruited in the control clinics were
also provided with their EPDS scores and advised to show
these to their health care providers. Subjects in this arm
were provided with enhanced usual care which included
all services normally available in the clinics; including
antidepressant medications, brief psychotherapeutic inter-
ventions, medical consultations, or external referral for
specialty treatment. Although all these options were po-
tentially part of usual care, in reality, unstructured coun-
selling was often all a patient with recognized perinatal
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depression will receive. Structured psychotherapy, consult-
ation with a doctor or referrals to a specialist were very
rarely offered. Our usual care is “enhanced” because pro-
viders in the control arm received training on the re-
cognition and management of depression based on the
specifications of the mhGAP-IG prior to commencement
of recruitment into the trial.
Training
Prior to recruitment of patients, providers in the interven-
tion arm received training on the recognition of depres-
sion, the delivery of the manualized intervention package,
the procurement and documentation of support and
supervision using mobile phones, and the use of the auto-
mated electronic support and documentation system. The
training consisted of didactic lectures enhanced with clin-
ical demonstrations and role playing over a 3-day period.
They had a further 3-day top-up training about a month
into the study to reinforce the skills previously acquired
and to identify any difficulties they had encountered in ad-
ministering the intervention.
Training of the providers in the control arm was con-
ducted separately. They received a 2-day training on
identification and standard treatment of depression. This
training was based on the mhGAP-IG but without de-
tailed PST training or guidelines and procedure for
obtaining structured support and supervision from phy-
sicians. The CMWs from the control clinics were also
provided with manuals providing general information
about perinatal depression.
Lay research assistants were recruited and trained. The
research assistants, all have at least a college degree, were
trained to administer the outcome assessment instruments
using the computer tablets provided. The research assis-
tants had a 4-day training in the administration of the
screening and outcome tools and conducted several trial
live interviews before commencing field work. For the
Bayley’s Scales of infant development, a Clinical Psycholo-
gist with vast experience in the use of the scale conducted
an initial one-week training. During this training, the
trainer gave didactic lectures on the use of the Scale and
demonstration assessments of 2 infants. This was followed
with supervised assessment of 2 infants by each of the 5
research assessors. Next, an inter-rater exercise with 20 in-
fants was conducted with each of the assessors conducting
4 assessments that were independently rated by the others.
Finally, a further paired assessment of 2 infants was inter-
changeably conducted by two assessors with one assessor
conducting the assessment and the other observing and
providing feedback afterwards.
Monitoring and supervision
The components of and tasks for each treatment session
as well as clinical decisions and steps were detailed in
manuals and charts provided to the CMW and primary
care physicians. To facilitate support and supervision to
the CMW, we developed a technological support plat-
form that incorporated a network of mobile telephones
linked to an online record system hosted on a secure
server. Mobile telephone lines were provided to each of
the trained CMW from the intervention clinics and their
supervisory community physicians and supervising psych-
iatrist. These mobile phone lines are linked in a closed
user group network where calls within the network are
free to facilitate consultation for difficult cases. The CMW
were encouraged to call patients to remind them of their
clinic appointments. Patients similarly received automated
voice messages to reinforce key messages provided during
sessions as well as remind them of clinic appointments.
Process evaluation
The Trial Manager monitored adherence to protocol
specification throughout the period of the intervention.
This was done by way of regular qualitative as well as
quantitative assessments. An assessment of fidelity in
the delivery of the intervention was conducted by an in-
dependent rater who observed three pre-selected live
sessions by each of the providers in the intervention arm
using a scale developed for the purpose.
Outcome measures
The outcome assessments, still on-going at the time of
this report, are conducted mostly in the patients’ homes
(except when patient prefers to have the assessment else-
where) by the trained research staff. Outcome assessors
have no involvement in delivering the intervention and
are rotated between MCCs to collect outcome data. All
consenting patients receive baseline assessment within
72 h of being screened and consenting to enter the trial.
Follow-up assessments are conducted at 2 months follow-
ing recruitment into the study and 3, 6, 9 and 12 months
after childbirth. All scales are administered in their Yoruba
versions, derived through standard iterative procedures
which we have employed in previous studies.
Primary outcome
The primary outcome is recovery from depression at
6 months postpartum (i.e. no longer having significant
depressive symptoms as indicated by EPDS score less
than 6).
Secondary outcomes
a) Score on the EPDS: in order to address the
possibility that even though individuals may have
recovered from a major depressive disorder,
significant depressive symptoms may still persist.
The EPDS is a 10-item screening instrument for
Gureje et al. BMC Psychiatry  (2015) 15:136 Page 6 of 9
depression. It has been validated and used in earlier
studies of perinatal depression in Nigeria [11].
b) Disability in the mother is assessed using the WHO
Disability Assessment Scale [37], previously used by
us [38];
c) Parenting skills (measured as maternal attitude and
adjustment to parenting) using the Maternal
Adjustment and Maternal Attitudes Questionnaire
(MAMAs), a widely used questionnaire with good
acceptability to women and good reliability [39] as
well as the Infant Toddler version of the Home
Inventory for Measurement of the Environment
(HOME-IT) [40]
d) An adapted version of the experience of stigma by
mothers with the 12-item Discrimination and Stigma
Scale, a cross-culturally valid tool that has been
previously used among Nigerian subjects [41]
e) The Client Service Receipt Inventory-PND version [42],
an adaptation of the Service Utilization Questionnaire
(SUQ) which we have used in previous studies to assess
health service utilization [43]
f ) Infant development: the child’s current level of
cognitive, language, personal-social, and fine and
gross motor development with an infant well-being
questionnaire. This questionnaire was developed by
us and it incorporates questions on child nutrition,
achievement of developmental milestones, illnesses,
immunization and measurements of the length/
height and weight and administered at 3, 6, 9 and
12 months. At 12 months, a comprehensive
assessment of motor and cognitive development is
conducted using the Bayley Scales of Infant
Development [44] which has been used previously
among Nigerian subjects [45].
The times and components of all scheduled outcome
assessments are shown in Fig. 2. Outcome data is col-
lected from every participant not known to have died at
the time of follow-up and who has not withdrawn con-
sent, regardless of compliance with allocated treatment.
Sample size
Experience from our previous studies in primary health
care (PHC) as well as from the control arm of a
Pakistani trial among women with perinatal depression
suggests a recovery rate of about 45 % for major depres-
sion with no active treatment and about 75 % with treat-
ment [29]. In a Chilean study of postnatal women with
depression, using a 3-point reduction in baseline score
of the depression assessment tool, remission rate was
1. EPDS 
2. CIDI 
SCREENING 
 BASELINE 
3 MONTHS 
POSTNATAL 
6 MONTHS 
POSTNATAL 
(PRIMARY 
OUTCOME 
ASSESSMENT) 
9 MONTHS 
POSTNATAL 
1. WHODAS 
2. SUQ 
3. DISC-12 
4. MAMAS
1.  EPDS 
2. WHODAS 
3. MAMAS 
1. Infant 
wellbeing 
questionnaire 
for 3months  
2. EPDS 
3. WHODAS 
4. SUQ 
1. Infant 
wellbeing 
questionnaire 
for 6 months 
2. EPDS 
3. CIDI 
4. WHODAS 
5. SUQ 
6. DISC 12 
7. MAMAS 
8. HOME –IT 
1. Infant 
wellbeing 
questionnaire 
for 9 months 
2. EPDS 
12 MONTHS 
POSTNATAL 
(SECONDARY 
OUTCOME 
ASSESSMENT)
1. Infant 
wellbeing 
questionnaire 
for 12 
 months 
2. EPDS 
3. WHODAS 
4. SUQ 
5. DISC-12 
6. MAMAS 
7. Bayley’s 
scale 
2 MONTHS 
AFTER 
BASELINE 
Abbreviations
EPDS- Edinburgh postnatal depression scale 
CIDI- Composite international diagnostic interview 
(depression module) 
WHODAS- WHO disability assessment schedule 
SUQ- Service utilization questionnaire 
DISC-12-Discrimination and stigma scale (12 item) 
MAMAS- Maternal adjustment and maternal 
attitudes questionnaire 
HOME-IT- Home inventory for measurement of the 
environment (infant toddler version)
Fig. 2 Timelines for outcome assessments
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57 % with no active treatment and 73 % with active
treatment [28]. For our sample size estimation, we
sought to detect an absolute difference of 15 percentage
points (40 % recovery in control and 55 % in interven-
tion groups respectively) at 6 months, a difference that
we think is both plausible for this type of intervention
and would promote changes in practice. In our pilot
study among antenatal women, we observed an intra-
cluster correlation coefficient (ICC) of 0.026 for EPDS
scores. In our pilot study among general adults with de-
pression, we were able to collect primary outcome at
6 months from 87.8 % of the participants. We expect a
higher follow-up rate among perinatal women who gen-
erally are less likely to move. However, we will use a
conservative 6-month follow-up rate of 85 % for our es-
timate. We also assume a 7 % infant death rate within
the period. The uninflated sample size requires 186 per
arm for analysis to detect a difference of 55 % vs 40 %
(equivalent odds ratio = 1.8) with 80 % power at the two-
sided 5 % alpha level. We originally aimed to recruit 50
individuals per MCC. With 43 individuals per cluster
available for the primary analysis and an ICC of 0.026,
the design effect is 2.09 giving a total number required
for analysis of 778. We therefore aimed to recruit a total
of 916 individuals from a total of 18 MCCs. As partici-
pant recruitment was slower than anticipated, in January
2014 we recruited and randomised a further 11 MCCs,
giving a total of 29 in the study. Participant recruitment
took place between July 2013 and October 2014. Out-
come assessments are still ongoing and will continue till
one year post-delivery assessment is concluded for the last
recruited participant.
Data analysis
A full statistical analysis plan will be developed before
any data are analyzed. The analysis and presentation of
the trial will be in accordance with CONSORT guide-
lines for cluster randomized trials [46, 47]. The primary
approach for comparative analyses will be to analyze
participants as randomized without imputation of miss-
ing data, and with due emphasis placed on confidence
intervals for the between-arm comparisons. We will use
descriptive statistics to assess balance between the trial
arms at baseline for both clinic and individual partici-
pant characteristics. In order to take appropriate account
of the hierarchical nature of the data, we will use multi-
variable mixed effects regression models to estimate re-
covery from depression at 6 months for intervention
group versus control, adjusting for baseline depression
and LGA as a stratification variable. In a secondary ana-
lysis, we will further adjust for any variables that were
imbalanced between trial arms at baseline. These analyses
will be repeated for secondary outcomes. We will conduct
sensitivity analyses to assess the potential effect of missing
data, and will investigate the effect of adherence with the
intervention. We will investigate whether between-group
differences vary over time using data from all follow-up
visits in repeated measures analyses.
We will investigate whether there is any differential ef-
fect of the intervention according to baseline symptom
severity (EPDS score <16, ≥16) by including appropriate
interaction terms in the primary regression model. Since
the trial is powered to detect overall differences between
groups rather than interactions of this kind, the results
will be interpreted with due caution.
Data analysis will be conducted once all follow-up is
complete. There are no planned interim analyses.
Discussion
EXPONATE is designed to provide empirical data that
will improve our understanding of the management of
perinatal depression in resource-constrained settings. Its
findings should inform the development of programs to
scale-up feasible and effective intervention through pri-
mary maternal care service.
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